Genetic Testing Market by Product, End-user, Application, and Geography - Forecast and Analysis 2020-2024
SKU ID : TNV-14966951 | Publishing Date : 14-Nov-2019 | No. of pages : 171
Detailed TOC of Genetic Testing Market by Product, End-user, Application, and Geography - Forecast and Analysis 2020-2024
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value Chain Analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Equipment - Market size and forecast 2019-2024
• Consumables - Market size and forecast 2019-2024
• Market opportunity by product
PART 07: MARKET SEGMENTATION BY END-USER
• Clinical diagnostics laboratories
• Hospitals
• Biopharmaceutical companies and research centers
• PART 08: MARKET SEGMENTATION BY APPLICATION
• Predictive and diagnostic testing
• Prenatal, newborn and preimplantation testing
• Pharmacogenomic testing
• Forensic, relationship and ancestry testing
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 10: CUSTOMER LANDSCAPE
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Advancements in next-generation sequencing
• Growing adoption of direct-to-consumer genetic tests in early
• disease diagnosis
• Growing adoption of pharmacogenetic testing in reducing adverse
• drug events
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Agilent Technologies Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina Inc.
• Myriad Genetics Inc.
• QIAGEN NV
• Quest Diagnostics Inc.
• Thermo Fisher Scientific Inc.
PART 16: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 17: EXPLORE TECHNAVIO
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Equipment - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Equipment - Year-over-year growth 2020-2024 (%)
Exhibit 22: Consumables - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Consumables - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Global genetic testing market segmentation by end-user 2019 (% share)
Exhibit 26: Global genetic testing market segmentation by application 2019 (% share)
Exhibit 27: Market share by geography 2019-2024 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 30: North America - Year-over-year growth 2020-2024 (%)
Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 33: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 35: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Customer landscape
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott Laboratories - Vendor overview
Exhibit 47: Abbott Laboratories - Product segments
Exhibit 48: Abbott Laboratories - Organizational developments
Exhibit 49: Abbott Laboratories - Geographic focus
Exhibit 50: Abbott Laboratories - Segment focus
Exhibit 51: Abbott Laboratories - Key offerings
Exhibit 52: Agilent Technologies Inc. - Vendor overview
Exhibit 53: Agilent Technologies Inc. - Business segments
Exhibit 54: Agilent Technologies Inc. - Organizational developments
Exhibit 55: Agilent Technologies Inc. - Geographic focus
Exhibit 56: Agilent Technologies Inc. - Segment focus
Exhibit 57: Agilent Technologies Inc. - Key offerings
Exhibit 58: bioMérieux SA - Vendor overview
Exhibit 59: bioMérieux SA - Business segments
Exhibit 60: bioMérieux SA - Organizational developments
Exhibit 61: bioMérieux SA - Geographic focus
Exhibit 62: bioMérieux SA - Key offerings
Exhibit 63: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 64: Bio-Rad Laboratories Inc. - Business segments
Exhibit 65: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 66: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 67: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 68: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 69: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 70: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 71: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 72: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 73: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 74: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 75: Illumina Inc. - Vendor overview
Exhibit 76: Illumina Inc. - Business segments
Exhibit 77: Illumina Inc. - Organizational developments
Exhibit 78: Illumina Inc. - Geographic focus
Exhibit 79: Illumina Inc. - Segment focus
Exhibit 80: Illumina Inc. - Key offerings
Exhibit 81: Myriad Genetics Inc. - Vendor overview
Exhibit 82: Myriad Genetics Inc. - Business segments
Exhibit 83: Myriad Genetics Inc. - Organizational developments
Exhibit 84: Myriad Genetics Inc. - Segment focus
Exhibit 85: Myriad Genetics Inc. - Key offerings
Exhibit 86: QIAGEN NV - Vendor overview
Exhibit 87: QIAGEN NV - Product segments
Exhibit 88: QIAGEN NV - Organizational developments
Exhibit 89: QIAGEN NV - Geographic focus
Exhibit 90: QIAGEN NV - Segment focus
Exhibit 91: QIAGEN NV - Key offerings
Exhibit 92: Quest Diagnostics Inc. - Vendor overview
Exhibit 93: Quest Diagnostics Inc. - Business segments
Exhibit 94: Quest Diagnostics Inc. - Organizational developments
Exhibit 95: Quest Diagnostics Inc. - Segment focus
Exhibit 96: Quest Diagnostics Inc. - Key offerings
Exhibit 97: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 98: Thermo Fisher Scientific Inc. - Business segments
Exhibit 99: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 100: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 101: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 102: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 103: Validation techniques employed for market sizing
Exhibit 104: Definition of market positioning of vendors